omniture
药明生物 WuXi Biologics

Latest News

WuXi Biologics Selected into the Hang Seng HK 35 Index

HONG KONG, Aug. 29, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-08-30 10:08 523

WuXi Biologics Reports Robust 2018 Interim Results

Revenue up 61.2% to a Record High of RMB1,054.4 Million Net Profit 270.7% of Same Period Last Year ...

2018-08-20 20:25 788

WuXi Biologics Commenced Process Validation in MFG2

* Produced 7 batches at 6,000L/12,000L bioreactor scale for three programs, the largest scale cel...

2018-07-31 07:55 449

WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3

- One of the largest biologics clinical manufacturing facilities globally with 6 production lines ...

2018-07-25 07:55 662

WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody

SHANGHAI and ENGLEWOOD CLIFFS, N.J., July 9, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leadi...

2018-07-09 22:00 740

WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership

WuXi Biologics' first collaborative project based on novel fully human antibody platform - HCAb ("h...

2018-06-25 07:55 743

WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center

WUXI, China, June 20, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access b...

2018-06-20 08:03 664

WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States

WORCESTER, Mass. and SHANGHAI, June 11, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading gl...

2018-06-11 08:34 816

WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership

BEIJING and SHANGHAI, May 29, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open...

2018-05-30 08:34 764

WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore

SINGAPORE and SHANGHAI, May 22, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global ope...

2018-05-22 18:34 829

WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer

Bioasis will draw on WuXi Biologics' expertise in developing complex biologic molecules for product...

2018-05-21 20:30 889

WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang

BEIJING, China, May 16, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access...

2018-05-16 18:09 913

WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

DUNDALK, Ireland and SHANGHAI, April 30, 2018 /PRNewswire/ -- An Taoiseach Leo Varadkar, Prime Mini...

2018-04-30 20:41 877

WuXi Biologics Wins CMO Leadership Award from Life Science Leader Magazine

SHANGHAI, April 16, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-04-17 08:13 447

WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

WUXI, China and BETHLEHEM, Pa., March 20, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading ...

2018-03-21 08:18 491

WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million

Revenue up 63.7% to a Record High of RMB1,618.8 Million Adjusted Net Profit up 85.1% to RMB408.1 Mi...

2018-03-19 20:41 751

WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership

SHANGHAI, March 8, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-03-09 11:43 624

WuXi Biologics Congratulates TaiMed on FDA Approval for Trogarzo

SHANGHAI, March 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access bio...

2018-03-07 12:24 674

WuXi Biologics Receives Asia's CMO of 2017 from BioPharma Industry Awards

SHANGHAI, March 5, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biol...

2018-03-06 14:11 467

WuXi Biologics Announces Positive Profit Alert

SHANGHAI, March 5, 2018 /PRNewswire/ -- WuXi Biologics (Stock Code: 2269.HK), a leading global open...

2018-03-05 17:48 501
12345